A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancerJohn F. R. Robertson, Julia M.W. Gee|Breast Cancer Research|2013Cited by 35